News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Teva Pharmaceutical Industries Limited (TEVA) Extends Collaboration with Proteologics by Licensing Three Programs



9/15/2008 8:45:28 AM

REHOVOT, Israel--(BUSINESS WIRE)--Proteologics Ltd., a leader in the ubiquitin system drug discovery, announces the licensing of three programs to Teva Pharmaceutical Industries Ltd. Under the agreement, Proteologics will discover and conduct early development of cancer treatments, while Teva will proceed with later stages of development, manufacturing and worldwide commercialization of the products.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES